Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states
Mallory L. MyersiD, Michael T. ConloniD, John R. GallagheriD, De’Marcus D. Woolfork, Noah D. Khorrami, William B. Park, Regan K. Stradtmann-Carvalho, Audray K. HarrisiD
Abstract
Influenza virus nucleoprotein (NP) is one of the most conserved influenza proteins. Both NP antigen and anti-NP antibodies are used as reagents in influenza diagnostic kits, with applications in both clinical practice, and influenza zoonotic surveillance programs. Despite this, studies on the biochemical basis of NP diagnostic serology and NP epitopes are not as developed as for hemagglutinin (HA), the fast-evolving antigen which has been the critical component of current influenza vaccines. Here, we characterized the NP serology of mice, ferret, and human sera and the immunogenic effects of NP antigen presented as different structural complexes. Furthermore, we show that a classical anti-NP mouse mAb HB65 could detect NP in some commercial influenza vaccines. MAb HB65 bound a linear epitope with nanomolar affinity. Our analysis suggests that linear NP epitopes paired with their corresponding characterized detection antibodies could aid in designing and improving diagnostic technologies for influenza virus.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 1.26
- Field percentile
- top 24%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
S. Boyoglu-Barnum, D. Ellis, … M. Kanekiyo·bioRxiv·May 30, 2020
- Mosaic display of stable hemagglutinin monomers induces broad immune responses
Hyo‐Jin Kim, Seong Cheol Min, … Kyung Hyun Kim·bioRxiv·Apr 10, 2024
- Influenza A (N1-N9) and Influenza B (B/Vic and B/Yam) Neuraminidase Pseudotypes as Tools for Pandemic Preparedness and Improved Influenza Vaccine design
K. A. S. da Costa, J. M. M. Del Rosario, … N. J. Temperton·bioRxiv·Sep 19, 2021
- A Universal, Single-Component Multilayered Self-Assembling Protein Nanoparticle Vaccine Based on Extracellular Domains of Matrix Protein 2 Against Both Influenza A and B
Yi-Nan Zhang, Keegan Braz Gomes, … Jiang Zhu·VaccinesPeer-reviewed·Aug 28, 2024
- Immune memory shapes human polyclonal antibody responses to H2N2 vaccination
Y. R. Yang, J. Han, … A. B. Ward·bioRxiv·Aug 23, 2023
- Impact of serum versus anticoagulant-containing plasma on influenza virusneuraminidase-based serological assays
Thi Hoai Thu Do, Stephen John Kent, … Marios Koutsakos·VaccinePeer-reviewed·Nov 13, 2025